Celldex Therapeutics Inc. CLDX
$32.02
▲ +4.37% 24H
About
Celldex Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted immunotherapies for cancer and other serious diseases. Its research platforms leverage novel antibody therapeutics, antibody-drug conjugates, and immune-activating agents desi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees198
TickerCLDX
Statistics
Market Cap$2.13B
Revenue (TTM)$1.5M
Net Income-$258.8M
Net Margin-16748.0%
EPS$-3.90
P/E-7.84
P/S2718.64
P/B4.37
EV/EBITDA-6.07
ROE-48.9%
Dividend Yield—
Price$32.02
Data: Twelve Data · Revenue = mcap / P/S